All presentations from the AACR Annual Meeting 2019 are now available free to everyone.

Login for full access:

Username and password are not your MyAACR account information

Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

clear all | select all

Conference Years:

clear all | select all

Days Within Meeting:

clear all | select all

Conferences:

Availability:

clear all | select all

Participation Type:

Presentations Access:

clear all | select all

Presentation Access:

clear all | select all

Topic Tracks*:

clear all | select all

Organ Site Tracks*:

  • Sort by:
  • Browse by:
<< first | < prev page: of 2 records per page: next > | last >>
pages: 1 2 presentations: 1 to 25 of 45
Controversies in Replication ctDNA Measurements
Key questions for ctDNA analysis
Paul T Spellman
Oregon Health Science Univ., Portland, OR, United States
from AACR Annual Meeting 2019 on March 29, 2019 3:00 PM-5:00 PM
Controversies in Replication ctDNA Measurements
Title to be announced
Jamie Platt
Inivata, Research Triangle Park, NC, United States
from AACR Annual Meeting 2019 on March 29, 2019 3:00 PM-5:00 PM
Controversies in Replication ctDNA Measurements
The dual roles of analytical and clinical data in ctDNA test validation
Justin Odegaard
Guardant Health Inc., Redwood City, CA, United States
from AACR Annual Meeting 2019 on March 29, 2019 3:00 PM-5:00 PM
Controversies in Replication ctDNA Measurements
Analytical validation of liquid biopsy assays: current challenges and opportunities
Mark Sausen
Personal Genome Diagnostics, Baltimore, MD, United States
from AACR Annual Meeting 2019 on March 29, 2019 3:00 PM-5:00 PM
Game-Changing Technologies for High-Throughput Functional Characterization of Cancer Gene Variants
Using large-scale mutagenesis to define cancer risk and understand inhibitor resistance
Douglas Fowler
University of Washington, Seattle, WA, United States
from AACR Annual Meeting 2019 on March 29, 2019 3:00 PM-5:00 PM
Game-Changing Technologies for High-Throughput Functional Characterization of Cancer Gene Variants
Escaping the confines of clinical genomics through massively-parallel variant phenotyping
Cory Matthew Johannessen
Broad Inst. of MIT and Harvard, Cambridge, MA, United States
from AACR Annual Meeting 2019 on March 29, 2019 3:00 PM-5:00 PM
Game-Changing Technologies for High-Throughput Functional Characterization of Cancer Gene Variants
Multiplexed functional assays to assess BRCA1 variants
Lea Starita
University of Washington, Seattle, WA, United States
from AACR Annual Meeting 2019 on March 29, 2019 3:00 PM-5:00 PM
Game-Changing Technologies for High-Throughput Functional Characterization of Cancer Gene Variants
CHASM plus reveals the scope of somatic missense mutations driving human cancers
Rachel Karchin
Johns Hopkins Univ., Baltimore, MD, United States
from AACR Annual Meeting 2019 on March 29, 2019 3:00 PM-5:00 PM
Immune-Targeted Biomarker Incorporation into Therapeutic Decision Making
The evolving landscape of biomarker selection in immunotherapy treatment decisions
Leena Gandhi
Lilly Oncology, Boston, MA, United States
from AACR Annual Meeting 2019 on March 29, 2019 3:00 PM-5:00 PM
Immune-Targeted Biomarker Incorporation into Therapeutic Decision Making
Predicting immunotherapy response with protein-based tools: PD-L1 and beyond
David L. Rimm
Yale Univ. School of Medicine, New Haven, CT, United States
from AACR Annual Meeting 2019 on March 29, 2019 3:00 PM-5:00 PM
Immune-Targeted Biomarker Incorporation into Therapeutic Decision Making
Cancer immunoediting: Framing response and resistance in immunotherapy
Gavin P. Dunn
Washington Univ. School of Medicine, Saint Louis, MO, United States
from AACR Annual Meeting 2019 on March 29, 2019 3:00 PM-5:00 PM
Immune-Targeted Biomarker Incorporation into Therapeutic Decision Making
Improving precision immuno-oncology using novel technologies
David A. Barbie
Dana-Farber Cancer Inst., Boston, MA, United States
from AACR Annual Meeting 2019 on March 29, 2019 3:00 PM-5:00 PM
Modulating the Gut Microbiome to Treat Dysbiosis and Cancer
  •  
  • Permission not
    granted for presentation
  •  
  •  
Cancer therapeutics: A view from the microbiota
Christian Jobin
Univ. of Florida, Gainesville, FL, United States
from AACR Annual Meeting 2019 on March 29, 2019 3:00 PM-5:00 PM
Modulating the Gut Microbiome to Treat Dysbiosis and Cancer
Dynamic monitoring of the dysbiotic microbiome
Jonathan Braun
Mt. Sinai Medical Center, Los Angeles, CA, United States
from AACR Annual Meeting 2019 on March 29, 2019 3:00 PM-5:00 PM
Modulating the Gut Microbiome to Treat Dysbiosis and Cancer
Identification and targeting microbial vulnerabilities
Ami S Bhatt
Stanford Medical School, Stanford, CA, United States
from AACR Annual Meeting 2019 on March 29, 2019 3:00 PM-5:00 PM
Modulating the Gut Microbiome to Treat Dysbiosis and Cancer
Encapsulated fecal transplant: It's not just for Clostridium difficile any more!
Elizabeth L Hohmann
Massachusetts General Hospital, Boston, MA, United States
from AACR Annual Meeting 2019 on March 29, 2019 3:00 PM-5:00 PM
Molecular Pathology for Cancer Researchers: Present and Future
Introduction
Massimo Loda
Cornell Univ., Ithaca, NY, United States
from AACR Annual Meeting 2019 on March 29, 2019 3:00 PM-5:00 PM
Molecular Pathology for Cancer Researchers: Present and Future
Pathology for cancer researchers: An overview
Jiaoti Huang
Duke Univ. School of Medicine, Durham, NC, United States
from AACR Annual Meeting 2019 on March 29, 2019 3:00 PM-5:00 PM
Molecular Pathology for Cancer Researchers: Present and Future
Antibody validation of immunohistochemistry (IHC) and in situ hybridization assays in tissue: Pitfalls, tips, and techniques
Angelo M De Marzo
John Hopkins Univ. School of Medicine, Baltimore, MD, United States
from AACR Annual Meeting 2019 on March 29, 2019 3:00 PM-5:00 PM
Molecular Pathology for Cancer Researchers: Present and Future
Molecular pathology and diagnostics
Andrea L Richardson
Johns Hopkins Univ. School of Medicine, Washington, DC, United States
from AACR Annual Meeting 2019 on March 29, 2019 3:00 PM-5:00 PM
Molecular Pathology for Cancer Researchers: Present and Future
Computational pathology, imaging, and artificial intelligence
Andrew H Beck
PathAI, Cambridge, MA, United States
from AACR Annual Meeting 2019 on March 29, 2019 3:00 PM-5:00 PM
Quantitative Approaches to Study Cancer Evolution and Heterogeneity
Tracking the arc of leukemia development from the beginning to the end
John E Dick
Univ. of Toronto, Toronto, ON, Canada
from AACR Annual Meeting 2019 on March 29, 2019 3:00 PM-5:00 PM
Quantitative Approaches to Study Cancer Evolution and Heterogeneity
Quantifying clonal dynamics through treatment and metastasis
Christina Curtis
Stanford University, Stanford, CA, United States
from AACR Annual Meeting 2019 on March 29, 2019 3:00 PM-5:00 PM
Quantitative Approaches to Study Cancer Evolution and Heterogeneity
Reconstructing the life history of cancers
Moritz Gerstung
European Bioinformatics Institute, Hinxton, Cambridgeshire, United Kingdom
from AACR Annual Meeting 2019 on March 29, 2019 3:00 PM-5:00 PM
Quantitative Approaches to Study Cancer Evolution and Heterogeneity
Evolution and heterogeneity in glioblastomas
Raul Rabadan
Columbia Univ. Medical Ctr., New York, NY, United States
from AACR Annual Meeting 2019 on March 29, 2019 3:00 PM-5:00 PM
<< first | < prev page: of 2 records per page: next > | last >>
pages: 1 2 presentations: 1 to 25 of 45